Recent Finacing
Recent Raise
Checkmate Pharmaceuticals is a clinical-stage biotech developing VLP‑delivered CpG‑A TLR9 agonists (CMP‑001/CYT003) to activate innate immunity and enhance PD‑1 inhibitor responses in refractory melanoma and other solid tumors.
